Treatment of immunocompromised COVID‐19 patients with convalescent plasma

Immunosuppressed patients such as solid organ transplant and hematologic malignancy patients appear to be at increased risk for morbidity and mortality due to coronavirus disease 2019 (COVID‐19) caused by SARS coronavirus 2 (SARS‐CoV‐2). Convalescent plasma, a method of passive immunization that has...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transpl Infect Dis
Main Authors: Fung, Monica, Nambiar, Ashok, Pandey, Suchi, Aldrich, J. Matthew, Teraoka, Justin, Freise, Christopher, Roberts, John, Chandran, Sindhu, Hays, Steven R., Bainbridge, Emma, DeVoe, Catherine, Roque Gardner, Annelys, Yokoe, Deborah, Henrich, Timothy J., Babik, Jennifer M., Chin‐Hong, Peter
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Case Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7537112/
https://ncbi.nlm.nih.gov/pubmed/32989856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tid.13477
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados